Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas
Conclusion
Salivary gland carcinomas show a high expression of pEGFR. This high expression correlates with lymph node metastasis, which supports the hypothesis that a high pEGFR expression facilitates lymphogenous metastasis. Due to this pEGFR expression, status may be a negative predictive factor in salivary gland carcinoma diagnostics. Patients with pN-positive salivary gland cancer may benefit from EGFR-inhibiting drugs.
Clinical relevance
The EGFR pathway may be a potential target for chemotherapy of advanced unresectable salivary gland carcinomas.
Source: Clinical Oral Investigations - Category: Dentistry Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Dentistry | Epithelial Cancer | Genetics | Head and Neck Cancer | Oral Cancer | Salivary Gland Cancer | Study